Page 7 - Ovarian Cancer Surgery - Quality Indicators-Summary
P. 7
QI 5 - TREATMENT PLANNED AND REVIEWED AT A MULTIDISCI-
PLINARY TEAM MEETING
TYPE Process indicator.
DESCRIPTION
The decision for any major therapeutic intervention has been taken by a
SPECIFICATIONS multidisciplinary team (MDT) including at least a surgical specialist as defined above
(QI 2 and QI 3), a radiologist, a pathologist (if a biopsy is available), and a physician
TARGET(S) certified to deliver chemotherapy (a gynecologic oncologist in countries where
SCORING RULE the subspecialty is structured and/or a medical oncologist with special interest in
gynecologic oncology).
Numerator: number of patients with advanced ovarian cancer for whom the deci-
sion for therapeutic intervention(s) has been taken by a MDT.
Denominator: all patients with advanced ovarian cancer undergoing therapeutic
intervention(s).
(≥ 95%
3 if the target is met.
QI 6 - REQUIRED PREOPERATIVE WORKUP
TYPE Process indicator.
DESCRIPTION
Unresectable parenchymal metastases have been ruled out by imaging. Ovarian
SPECIFICATIONS and peritoneal malignancy secondary to gastrointestinal cancer has been ruled out
by suitable methods e.g. plasma CA 125 and CEA levels, and/or by biopsy under
TARGET(S) radiologic or laparoscopic guidance.
SCORING RULE
Numerator: number of patients with advanced ovarian cancer who had undergone
cytoreductive surgery and who were offered minimum preoperative workup as
defined above.
Denominator: all patients with suspected advanced ovarian cancer who underwent
cytoreductive surgery.
≥ 95%
3 if the target is met.
• ADVANCED (STAGE III-IV) OVARIAN CANCER SURGERY - QUALITY INDICATORS • 7
